Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Restore Medical Announces Successful First-In-Human Preliminary Results of Its CONTRABAND™ System for Symptomatic Systolic Heart Failure Patients
Restore Medical, a privately held medical device company, has successfully completed enrollment of the First […]
Mario Franco Ruiz, H&T Presspart, on Innovation for Medical Devices
In the video, Mario Franco Ruiz, Sales Manager at H&T Presspart, discusses the company’s latest […]
Artax Biopharma Appoints Andre Hoekema, Ph.D., to Company's Board of Directors
Artax Biopharma, a clinical-stage biotechnology company focused on transforming the treatment of T-cell-mediated diseases, today […]
Virion Therapeutics Presents Promising Preclinical Cancer Data When Using a Novel Genetically Encoded Checkpoint Modifier-Based Immunotherapy
Virion Therapeutics, a clinical-stage biotech company focused on the development of novel, adaptable, and accessible CD8+ T […]
BioMarin Provides Update on FDA Review of ROCTAVIAN™ (Valoctocogene Roxaparvovec) Gene Therapy for Adults with Severe Hemophilia A
BioMarin Pharmaceutical, a global biotechnology company dedicated to transforming lives through genetic discovery, today announced […]
Jared O'Connell, Honeywell, on Sustainability and Innovation
In this video, Jared O’Connell, the General Manager of Healthcare Packaging at Honeywell, discusses what […]
Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA
Corbus Pharmaceuticals, a precision oncology company, today announced the appointment of Yong Ben, M.D., MBA, […]
Cantex and Miami Cancer Institute Announce FDA Clearance for a Clinical Trial Investigating Azeliragon Combined with Stereotactic Radiosurgery for the Treatment of Brain Metastases
Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other […]
Cardinal Health's Outcomes™ Collaborates with Signify Health to Offer In-Home Medication Therapy Management
Cardinal Health today announced its collaboration with Signify Health to offer in-home clinical and medication management […]
Noema Pharma Raises CHF 103 Million (USD 112 Million) in Series B Financing Round led by Forbion and Jeito Capital
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced that […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more